دورية أكاديمية

Use of BRASS in sedated critically-ill patients as a predictable mortality factor: BRASS-ICU.

التفاصيل البيبلوغرافية
العنوان: Use of BRASS in sedated critically-ill patients as a predictable mortality factor: BRASS-ICU.
المؤلفون: Legros, Vincent, Mourvillier, Bruno, Floch, Thierry, Candelier, Quentin, Rosman, Jeremy, Lafont, Bruno, Farkas, Jean-Christophe, Bard, Mathieu, Kanagaratnam, Lukshe, Mateu, Philippe
المصدر: Neurological Research; Apr2021, Vol. 43 Issue 4, p283-290, 8p
مصطلحات موضوعية: BRASS, MORTALITY, ARTIFICIAL respiration, SUFENTANIL, BRAIN stem
مستخلص: Objectives: To demonstrate that a BRASS score≥ 3 at admission of intubated, ventilated and sedated patients is predictive of mortality Methods: we have realized an Observational prospective multicenter study. All Major patients without neurological history, admitted to ICU for a non-neurological cause, sedated and admitted under mechanical ventilation were included. Results: One hundred and ten patients were included, the BRASS score as well as the FOUR and RASS scores were collected. At day 28, patients with a BRASS score ≥ 3 had an excess mortality (OR 3.29 – CI 95% [1.42–7.63], p = 0.005) as well as day 90 (OR 2.65 – CI 95% [1.19–5.88], p = 0.02), without impact on the delirium measured by CAM-ICU (OR 1.8 – CI 95% [0.68–4.77], p = 0.023). After adjustment with SAPS II, FOUR and RASS, difference in mortality was not any more different. It is also noted that patients with BRASS ≥ 3 are more sedated (RASS: −5 [−5 – −5] vs −4 [−5 – −3], p < 0.0001) and more comatose (FOUR: 2 [1–4] vs 6 [4–9], p < 0.0001), and have higher doses of midazolam (10 mg/h [5–15] vs 7.5 mg/h [5–10], p = 0.02) and sufentanil (20 μg/h [15–22.5] vs 10 [10–12.5], p = 0.01). Conclusions: The early alteration of brainstem reflexes measured by the BRASS score was not independently predictable in terms of mortality in the non-neurological ICU patients, admitted under sedation and mechanical ventilation. Trial registration: ClinicalTrials.gov Identifier: NCT03835091,Registered 8 February 2019 – prospectively registered, [ABSTRACT FROM AUTHOR]
Copyright of Neurological Research is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:01616412
DOI:10.1080/01616412.2020.1849901